Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

被引：0
|
作者：
Ko, Sun-Hye
Lee, Jung-Hee
Park, Han-Seung
Lee, Je-Hwan
Choi, Eun-ji
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Lee, Kyoo Hyung
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3214
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    Kröger, N
    Bornhäuser, M
    Ehninger, G
    Schwerdtfeger, R
    Biersack, H
    Sayer, HG
    Wandt, H
    Schäfer-Eckardt, K
    Beyer, J
    Kiehl, M
    Zander, AR
    ANNALS OF HEMATOLOGY, 2003, 82 (06) : 336 - 342
  • [32] A suitable conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia Abstract
    Imamura, Masahiro
    JOURNAL OF STEM CELLS & REGENERATIVE MEDICINE, 2011, 7 (03): : P98 - P148
  • [33] Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Beyer, Kristen
    Proli, Anthony
    Zheng, Junting
    Devlin, Sean
    Bhatt, Valkal
    Lin, Andrew
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Perales, Miguel
    Giralt, Sergio
    Castro-Malaspina, Hugo
    Tamari, Roni
    BLOOD, 2016, 128 (22)
  • [34] Busulfan-Based Allogeneic Hematopoietic Cell Transplantation with Various Donor Type Including Haploidentical Familial Mismatched Donor as Post Remission Therapy in Adult Acute Lymphoblastic Leukemia
    Kim, Dae-Young
    Park, Han-Seung
    Choi, Eunji
    Lee, Je-Hwan
    Lee, Jung-Hee
    Jeon, Mijin
    Lee, Young-Shin
    Kang, Young-Ah
    Lee, Kyoo-Hyung
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S331 - S332
  • [35] Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Beyer, Kristen
    Proli, Anthony J.
    Zheng, Junting
    Bhatt, Valkal
    Lin, Andrew
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Perales, Miguel-Angel
    Castro-Malaspina, Hugo
    Giralt, Sergio A.
    Tamari, Roni
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S263 - S263
  • [36] Comparison of melphalan- And busulfan-based myeloablative conditioning in children undergoing allogeneic transplantation for acute myeloid leukemia or myelodysplasia
    Oshrine, Benjamin
    Adams, Lauren
    Nguyen, Anh Thy H.
    Amankwah, Ernest
    Shyr, David
    Hale, Gregory
    Petrovic, Aleksandra
    PEDIATRIC TRANSPLANTATION, 2020, 24 (04)
  • [37] Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia
    Al Malki, Monzr M.
    Aldoss, Ibrahim
    Stiller, Tracey
    Nakamura, Ryotaro
    Snyder, David S.
    Forman, Stephen J.
    Pullarkat, Vinod
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 519 - 522
  • [38] Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
    Pidala, Joseph
    Kim, Jongphil
    Anasetti, Claudio
    Kharfan-Dabaja, Mohamed A.
    Nishihori, Taiga
    Field, Teresa
    Perkins, Janelle
    Perez, Lia
    Fernandez, Hugo F.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [39] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    N. Kröger
    M. Bornhäuser
    G. Ehninger
    R. Schwerdtfeger
    H. Biersack
    H. G. Sayer
    H. Wandt
    K. Schäfer-Eckardt
    J. Beyer
    M. Kiehl
    A. R. Zander
    Annals of Hematology, 2003, 82 : 336 - 342
  • [40] Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
    Joseph Pidala
    Jongphil Kim
    Claudio Anasetti
    Mohamed A Kharfan-Dabaja
    Taiga Nishihori
    Teresa Field
    Janelle Perkins
    Lia Perez
    Hugo F Fernandez
    Journal of Hematology & Oncology, 3
12345